Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal symptoms in patients with history of colorectal cancer surgery; crossover study - Gastrointestinal transit time as an indicator -

Trial Profile

Clinical efficacy of Daikenchuto (DKT: TJ-100) for gastrointestinal symptoms in patients with history of colorectal cancer surgery; crossover study - Gastrointestinal transit time as an indicator -

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Mar 2013

At a glance

  • Drugs TJ 100 (Primary)
  • Indications Gastrointestinal disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Mar 2013 Planned End Date changed from 1 Mar 2013 to 1 Mar 2015 as reported by University Hospital Medical Information Network - Japan.
    • 11 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top